跳至主要内容
临床试验/NCT06752733
NCT06752733进行中(未招募)不适用

The Association Between Myocardial Stunning and Long-term Prognosis After Electrical Cardioversion in Patients with Atrial Fibrillation

Korea University Guro Hospital1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2024年2月20日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
160
试验地点
1
主要终点
The recurrence of atrial arrhythmia

研究概览

简要总结

The goal of this observational study is to evaluate cardiac stunning and electrocardiographic parameters through transthoracic echocardiography and 24 hours ECG conducted immediately following electrical cardioversion. The main question it aims to answer is:

Do echocardiographic and electrocardiographic parameters relating to cardiac stunning predict atrial fibrillation (AF) recurrence rates after electrical cardioversion?

Participants will undergo echocardiography and a 24-hour Holter monitoring immediately after electrical cardioversion.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with atrial fibrillation
  • Patients with persistent or symptomatic atrial fibrillation who are candidates for electrical cardioversion
  • Patients eligible for anticoagulation therapy for thromboembolism prevention before and after the procedure
  • Patients who can understand and provide written informed consent

排除标准

  • Patients under 18 years of age or over 80 years of age
  • Patients who do not consent to participate in the study
  • Patients with severe coronary artery stenosis
  • Patients with severe hepatic dysfunction
  • Patients with severe renal dysfunction
  • Patients with severe valvular heart disease
  • Patients with a high risk of severe bleeding
  • Patients with a history of atrial fibrillation-related catheter ablation or cardiac surgery
  • Patients with an expected life expectancy of less than 1 year
  • Potentially pregnant individuals
  • Patients deemed unsuitable for the study by the investigator

结局指标

主要结局

The recurrence of atrial arrhythmia

时间窗: From enrollment to the end of treatment at 12 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Roh Seung Young

Professor

Korea University Guro Hospital

研究点 (1)

Loading locations...

相似试验